Amgen

raised boxing glove with confetti falling around it
Biotech

Roche orchestrates phase 3 lung cancer win over Amgen and BMS

Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial.
Nick Paul Taylor Jul 2, 2026 8:30am
FDA stop sign
Favicon Fierce Pharma

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Amgen loses in Harbour antibody patent case, ordered to pay $20M+

Jun 15, 2026 10:34am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders

Jun 5, 2026 8:30am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Former FDA leader takes new biotech Turn—Chutes & Ladders

May 22, 2026 8:30am
Quantinuum vacuum chamber hero quantum computer

Amgen-backed quantum computing firm plans IPO

May 10, 2026 8:25am